nilotinib
Showing 1 - 25 of 110
Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)
No longer available
- Acute Lymphoblastic Leukemia (ALL)
- Nilotinib
- (no location specified)
Aug 5, 2022
Peritoneal Carcinomatosis, Peritoneal Tumors, Ovarian Cancer Trial run by the National Cancer Institute (NCI) (Paclitaxel,
Not yet recruiting
- Peritoneal Carcinomatosis
- +7 more
- Paclitaxel
- Nilotinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)
Not yet recruiting
- Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
- Asciminib
- Nilotinib
- (no location specified)
Jul 11, 2022
Chronic Myeloid Leukemia Trial in New York (Nilotinib)
Completed
- Chronic Myeloid Leukemia
- Nilotinib
-
New York, New YorkWeill Cornell Medical College
Mar 24, 2022
Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Nilotinib
- Nilotinib
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Mar 15, 2022
GIST and CML Trial in Worldwide (AMN107)
Active, not recruiting
- GIST and CML
- Nilotinib
-
Albany, New York
- +32 more
Oct 4, 2022
Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)
Recruiting
- Chronic Myelogenous Leukemia
- Nilotinib
-
Beirut, LebanonAmerican University of Beirut Medical Center
Feb 14, 2022
Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- Nilotinib
-
HUS, Finland
- +6 more
Apr 19, 2022
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)
Completed
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Nilotinib
-
Angers, France
- +9 more
Aug 17, 2022
Chordoma Trial in Boston (Nilotinib, Radiation therapy)
Active, not recruiting
- Chordoma
- Nilotinib
- Radiation therapy
-
Boston, MassachusettsMassachusetts General Hospital
Oct 27, 2021
Ataxia, Cerebellar, Ataxia, Progressive Trial in Seoul (Nilotinib)
Completed
- Ataxia, Cerebellar
- Ataxia, Progressive
- Nilotinib
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 23, 2021
Hypereosinophilic Syndrome (HES) Trial (Nilotinib)
No longer available
- Hypereosinophilic Syndrome (HES)
- Nilotinib
- (no location specified)
Sep 14, 2021
Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor, Tenosynovial Giant Cell Tumor Trial in United States
Active, not recruiting
- Pigmented Villonodular Synovitis
- +2 more
- nilotinib
-
Santa Monica, California
- +6 more
Jan 31, 2022
Treatment, Stem Cell Transplantation Trial in Italy (Nilotinib, Imatinib)
Completed
- Treatment
- Stem Cell Transplantation
- Nilotinib
- Imatinib
-
Ancona, Italy
- +34 more
Oct 10, 2022
Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)
Active, not recruiting
- Chronic Myeloid Leukemia
- TKI discontinuation
- nilotinib
-
Freiburg, Baden-Württemberg, Germany
- +14 more
Nov 4, 2021
Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid
Recruiting
- CML-CP; Mutation;Suboptimal Response or Failure in TKI
- Flumatinib
- Nilotinib
-
Wuhan, Hubei, ChinaWeiming Li
May 31, 2021
Healthy Trial (Nilotinib)
Completed
- Healthy
- Nilotinib
- (no location specified)
Dec 6, 2020
Chronic Myeloid Leukemia Trial in Italy (Nilotinib)
Completed
- Chronic Myeloid Leukemia
- Nilotinib
-
Ascoli Piceno, Italy
- +21 more
Jan 3, 2022
Chronic GVHD Trial in Israel, Italy (nilotinib)
Completed
- Chronic Graft Versus Host Disease
- nilotinib
-
Tel Hashomer, Israel
- +11 more
Aug 19, 2021
Chronic Myeloid Leukemia Trial in Germany (Nilotinib)
Completed
- Chronic Myeloid Leukemia
- Nilotinib
-
Mannheim, Baden-Wuerttemberg, Germany
- +69 more
Mar 21, 2022
Chronic Phase Chronic Myeloid Leukemia Trial in Tampa (Nilotinib, Ruxolitinib)
Completed
- Chronic Phase Chronic Myeloid Leukemia
- Nilotinib
- Ruxolitinib
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 4, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Nilotinib
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 19, 2021